Skip to main content

Daniel Grosslight

Analyst

Citi

Equibles does not estimate personal net worth.

About Daniel Grosslight

Daniel Grosslight is recorded as Analyst at Citi. Daniel Grosslight has spoken on 15 earnings calls across 9 companies, most recently for DENTSPLY SIRONA Inc. on August 6, 2026. Those appearances were for Accendra Health Inc/Va/ (ACH), Mckesson Corp (MCK), Cencora, Inc. (COR), DENTSPLY SIRONA Inc. (XRAY), GMR Solutions Inc. (GMRS) and 4 other companies. The companies whose calls Daniel Grosslight spoke on are classified in the Healthcare sector.

Daniel Grosslight on recent calls

“And just an accounting question on the tariff impact or the tariff benefit this quarter.”
Analyst — Citi, Earnings conference call (announced in 8-K) ·
“Post your IPO, you're now levered at around three and a half times. I'm curious how this changes your capacity and appetite for acquisitions. I think you ranked it as number three in terms of priorities behind debt repayment.”
Analyst — Citi, GMR Solutions Inc. Q1 FY2026 Earnings Call ·
“Global dental growth was relatively strong across both merchandise and equipment. You mentioned a couple times that you're taking share here, but also the underlying market seems to have recovered somewhat.”
Analyst — Citi, Henry Schein Inc Q1 FY2026 Earnings Call ·
“I was hoping you could comment a little bit more on the uptake you're seeing in your new subscription offerings and how we should think about growth in those offerings in 2026, particularly around weight loss and the introduction of more competition on the weight loss side of things.”
Analyst — Citi, GoodRx Holdings, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • Citi

    Analyst

    Source not stated

    Current

Company network

Recent activity